36 results on '"Van Elssen, Catharina"'
Search Results
2. Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
3. NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?
4. Low Levels of Serum and Intracellular Vitamin C in Hospitalized COVID-19 Patients.
5. Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer
6. MM-349 Talquetamab (Tal), a GPRC5D×CD3 Bispecific Antibody (BsAb), in Combination With Pomalidomide (Pom) in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Efficacy and Safety Results From the Phase 1b MonumenTAL-2 Study
7. Talquetamab (Tal), a GPRC5D×CD3 Bispecific Antibody (BsAb), in Combination With Pomalidomide (Pom) in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Efficacy and Safety Results From the Phase 1b MonumenTAL-2 Study
8. Increased CD8 T‐cell immunity after COVID‐19 vaccination in lymphoid malignancy patients lacking adequate humoral response: An immune compensation mechanism?
9. No Effect of Vitamin C Administration on Neutrophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Placebo-Controlled Trial.
10. Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis.
11. Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice
12. The impact of donor type on resource utilisation and costs in allogeneic haematopoietic stem cell transplantation in the Netherlands.
13. Expression of aberrantly glycosylated Mucin-1 in ovarian cancer
14. Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML Patients Correlates with Clinical Response and MRD Conversion
15. Use of an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML-Patients Results in MRD Conversion, Improved Relapse-Free Survival and Vaccine Induced Immune Responses to Tumor Antigens
16. Real‐world experience: Introduction of T cell replete haploidentical transplantations in a single center.
17. T cells fail to develop in the human skin-cell explants system; an inconvenient truth
18. NK cell alloreactivity in acute myeloid leukemia in the post‐transplant cyclophosphamide era.
19. Natural killer cell alloreactivity is not beneficial in haploidentical bone marrow transplantation with post-transplantation cyclophosphamide for multiple myeloma: Results of a prospective phase 2 clinical trial
20. P1387: TREATMENT WITH A LEUKEMIA-DERIVED DENDRITIC CELL VACCINE INDUCES INNATE AND ADAPTIVE IMMUNE RESPONSE CORRELATING WITH CLINICAL RESPONSE IN AML PATIENTS IN CR1 WITH MEASURABLE RESIDUAL DISEASE.
21. Influence of Vitamin C on Lymphocytes: An Overview.
22. NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?
23. Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity.
24. Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.
25. In vitro–differentiated T/natural killer–cell progenitors derived from human CD34+ cells mature in the thymus
26. Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination.
27. Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs.
28. A randomised controlled phase II trial of preoperative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.
29. Inflammation restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation.
30. Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies
31. T cells fail to develop in the human skin-cell explants system; an inconvenient truth.
32. Klebsiella pneumoniae-triggered DC recruit human NK cells in a CCR5-dependent manner leading to increased CCL19-responsiveness and activation of NK cells.
33. The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review.
34. A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.
35. Easy-to-Use HPLC Method to Measure Intracellular Ascorbic Acid Levels in Human Peripheral Blood Mononuclear Cells and in Plasma.
36. Natural killer cells: the secret weapon in dendritic cell vaccination strategies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.